Dr. Martens plc (DOCS.L, DRMTY), a British footwear and clothing brand, announced on Thursday reaffirmed its full-year 2026 guidance, as this year's trading has met expectations.
The company said it is focused on putting its new consumer-first Levers for Growth strategy into action, which will be introduced during the June 5 results.
The strategy builds on efforts made in full-year 2025 to stabilise the business. It aims to leverage the company's strengths and tap into new markets and profit opportunities.
The key areas include reaching more consumers, driving more product purchase occasions, curating market-right distribution, and simplifying the operating model.
An update on early progress will be provided with the first-half results in November.
Regionally, the Americas Direct-to-Consumer business is performing well, especially in retail with strong full-price sales. The EMEA DTC business is more mixed, with the UK market still facing tough conditions.
In the Asia-Pacific region, the business continues to grow, led by strong sales in South Korea, particularly in the core shoes category.
Looking ahead, the company said that the global Autumn/Winter order books are good.
Orders in the EMEA region are higher than last year, while in the Americas, they are roughly the same but cover a wider range of products.
The company expects most of its profits to come in the second half of the year.
Dr. Martens is currently trading, 1.64% higher at 77.40 pence on the London Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.